Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-01AVXL3Form 3 Filing - Axel Paeger Director Ownership Statement for Anavex Life Sciences Corp.
This is a Form 3 filing by Axel Paeger, a director of Anavex Life Sciences Corp. (AVXL), reporting his initial statement of beneficial ownership of securities. Filed on May 1, 2026, with a reporting period ending February 23, 2026, the document indicates that Paeger currently owns no securities in the company. The fili...
Small CapBiotechnology
2026-05-01BRNS3Power of Attorney for Douglas Swirsky
This filing details a Power of Attorney granted by Douglas Swirsky, Principal Accounting Officer of Barinthus Biotherapeutics plc, to William Enright, Robert E. Puopolo, and Marishka DeToy. This grants them the authority to execute and file, on behalf of Mr. Swirsky, various SEC forms including Forms 3, 4, and 5, Sched...
Nano CapBiotechnology